Psychosomatic Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burg, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burg, M. M.
Related Collections
Right arrow Social Support
Right arrow Therapeutic Interventions
Right arrow Coronary Artery Disease

Low Perceived Social Support and Post–Myocardial Infarction Prognosis in the Enhancing Recovery in Coronary Heart Disease Clinical Trial: The Effects of Treatment

Matthew M. Burg, PhD, John Barefoot, PhD, Lisa Berkman, PhD, Diane J. Catellier, DrPH, Susan Czajkowski, PhD, Patrice Saab, PhD, Marc Huber, MS, Vicki DeLillo, PhD, Pamela Mitchell, PhD, RN, Judy Skala, PhD, C. Barr Taylor, MD for the ENRICHD Investigators*

From the Department of Psychiatry and Behavioral Sciences, Duke University, Durham, North Carolina (J.B.); Department of Society, Human Development, and Health, Harvard University, Cambridge, Massachusetts (L.B.); Department of Biostatistics, University of North Carolina School of Medicine, Chapel Hill, North Carolina (D.J.C.); NHLBI, Bethesda, Maryland (S.C.); Department of Psychology, University of Miami, Miami, Florida (P.S.); Department of Biostatistics, University of North Carolina School of Medicine, Chapel Hill, North Carolina (M.H.); College of Public Health, University of Arkansas, Little Rock, Arkansas (V.D.); School of Nursing, University of Washington, Seattle Washington (P.M.); Department of Psychiatry, Washington University, St. Louis, Missouri (J.S.); Department of Psychiatry, Stanford University, Palo Alto, California (C.B.T.).



View larger version (19K):

[in a new window]
  		Figure 1. Baseline to 6-month change in ESSI score for each LPSS risk group. Textbox contains N = . * Indicates significance at the p < .05 level.

 


View larger version (19K):

[in a new window]
  		Figure 2. Baseline to 12 month change in ESSI score for each LPSS risk group. Textbox contains N = .

 


View larger version (18K):

[in a new window]
  		Figure 3. Percent of patients in each LPSS risk group no longer meeting LPSS criteria at 6 months. Textbox contains N = . * Indicates significance at the p < .05 level.

 


View larger version (19K):

[in a new window]
  		Figure 4. Percent of patients in each LPSS risk group no longer meeting LPSS criteria at 12 months. Textbox contains N = .

 




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Psychosomatic Society